tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IPHYF Stock Latest News

FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab
Company AnnouncementsFDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab
3d ago
6K
Buy Rating for Innate Pharma: Lacutamab’s Breakthrough Designation and Market Potential Drive Positive Outlook
PremiumRatings
Buy Rating for Innate Pharma: Lacutamab’s Breakthrough Designation and Market Potential Drive Positive Outlook
4d ago
IPHA
Innovative Potential of Innate Pharma’s IPH4502 in Overcoming Drug Resistance and Expanding Therapeutic Impact
PremiumRatings
Innovative Potential of Innate Pharma’s IPH4502 in Overcoming Drug Resistance and Expanding Therapeutic Impact
15d ago
IPHA
Innate Pharma Begins Phase 1 Study of New Cancer Therapy
PremiumCompany Announcements
Innate Pharma Begins Phase 1 Study of New Cancer Therapy
25d ago
6K
Innate Pharma doses first patient in IPH4502 study
PremiumThe Fly
Innate Pharma doses first patient in IPH4502 study
25d ago
IPHA
Innate Pharma to Showcase ADC Innovations at Upcoming New York Event
PremiumCompany AnnouncementsInnate Pharma to Showcase ADC Innovations at Upcoming New York Event
1M ago
6K
Innate Pharma Reports Share and Voting Rights Update
Premium
Company Announcements
Innate Pharma Reports Share and Voting Rights Update
1M ago
6K
Innate Pharma Unveils Growth Strategy Focused on Innovation and Partnerships
Premium
Company Announcements
Innate Pharma Unveils Growth Strategy Focused on Innovation and Partnerships
1M ago
6K
Innate Pharma to Present at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Innate Pharma to Present at J.P. Morgan Healthcare Conference
2M ago
6K
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
VIR
BCYC
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
KOD
AGIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
KOD
AGIO
Innate Pharma SA Reveals Promising Lacutamab Trial Results
PremiumCompany AnnouncementsInnate Pharma SA Reveals Promising Lacutamab Trial Results
2M ago
6K
Innate Pharma announces new data from TELLOMAK study
Premium
The Fly
Innate Pharma announces new data from TELLOMAK study
2M ago
IPHA
Innate Pharma Secures $7.9M Investment for Lymphoma Treatment
Premium
Company Announcements
Innate Pharma Secures $7.9M Investment for Lymphoma Treatment
3M ago
6K
Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
PremiumThe Fly
Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
3M ago
IPHA
Innate Pharma SA’s Innovations Spotlighted at ASH 2024
PremiumCompany Announcements
Innate Pharma SA’s Innovations Spotlighted at ASH 2024
3M ago
6K
Innate Pharma Announces 2025 Financial Calendar
PremiumCompany Announcements
Innate Pharma Announces 2025 Financial Calendar
3M ago
6K
Innate Pharma’s IPH6501: A Promising Cancer Therapy
PremiumCompany Announcements
Innate Pharma’s IPH6501: A Promising Cancer Therapy
3M ago
6K
Innate Pharma publishes IPH6501 data in Science Immunology
PremiumThe FlyInnate Pharma publishes IPH6501 data in Science Immunology
3M ago
IPHA
Innate Pharma’s New CEO and Promising FDA Feedback
Premium
Company Announcements
Innate Pharma’s New CEO and Promising FDA Feedback
3M ago
6K
Innate Pharma Showcases Promising Cancer Therapies
Premium
Company Announcements
Innate Pharma Showcases Promising Cancer Therapies
4M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >